Changing of Prostate Specific Antigen Value in Patients With Covid-19
- Conditions
- Prostate Specific AntigenCovid19
- Interventions
- Other: PSA value
- Registration Number
- NCT05009186
- Lead Sponsor
- Saglik Bilimleri Universitesi
- Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.
- Detailed Description
Patients with positive PCR test results were included in the study. The age of the patient and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both at the time the patients applied and three weeks after the patient recovered. PSA and free PSA were also measured in the same way. Patients whose symptoms improved and the PCR test result was negative were considered as recovered.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 100
- Male patients (>45 and <70 years of age) positive PCR test results were included in the study
- The patients <45 and >70 years of age who described lower urinary tract symptoms who had urinary tract infection who a history of prostate biopsy and previous high level of PSA who history of prostatitis were excluded.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Covid-19 group PSA value We will measure the PSA value during and after Covid-19 infection in the same group via paired simple t test
- Primary Outcome Measures
Name Time Method PSA value 2 months prostate specific antigen
- Secondary Outcome Measures
Name Time Method Ferritin, CRP 2 months
Trial Locations
- Locations (1)
Omer Gokhan Doluoglu
🇹🇷Ankara, Altindag, Turkey